PD67-12 BENEFIT OF EARLY TREATMENT WITH BONE-MODIFYING AGENTS FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH GENITOURINARY CANCER WITH BONE METASTASIS: A LARGE SCALE MULTI-INSTITUTIONAL STUDY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.